Common Antibiotic Azithromycin Reduces Low Birth Weight

Azithromycin, a common antibiotic taken during pregnancy could reduce low birth weight and premature births, reveals a research.

The systematic review, led by the Murdoch Children’s Research Institute (MCRI) and published in The Lancet EClinicalMedicine, found that the antibiotic, azithromycin, reduced low birth weight and prematurity in Africa and Asia but didn’t lower infant deaths, infections and hospital admissions.

Breathing Difficulties in Low Birth Weight Babies: New Findings
The proportion of Swedish adults with low cardiorespiratory fitness almost doubled from 27 percent in 1995 to 46 percent in 2017, revealed study.

‘Globally, infections cause about 21 per cent of 2.4 million neonatal deaths each year and 52 per cent of all under five deaths, with a disproportionate amount occurring in low- and middle-income countries. ’

The researchers reviewed 14 studies undertaken in African and Asian countries, involving 17,594 participants.

Azithromycin is an inexpensive antibiotic widely used to treat chest and ear infections. In pregnancy it has been specifically used in the past to treat STIs and, alongside other antimalarial drugs, to prevent adverse consequences of malaria on maternal and fetal outcomes and caesarean wound infections.

MCRI researcher Dr Maeve Hume-Nixon said it was unclear whether azithromycin would improve perinatal and neonatal outcomes in non-malaria endemic settings, and the potential harm on stillbirth rates needed further investigation.

Pre-Eclampsia - Causes - Symptoms - Diagnosis - Treatment - FAQs
In pre eclampsia a pregnant woman develops high blood pressure and proteinuria during pregnancy.

Dr Hume-Nixon said these findings emphasised the importance of similar MCRI-led research currently being done in Fiji.

“This review found that there was uncertainty about the potential benefits of this intervention on neonatal deaths, admissions and infections, and potential harmful effects on stillbirth despite biological reasons why this intervention may have benefits for these outcomes,” she said.

Quiz on Myths about Pregnancy
Pregnancy is probably one of the most common medical conditions that is surrounded by myths and false beliefs. Here is a quiz that would help you in separating pregnancy myths from the facts.

“Therefore, results from studies like ours underway in Fiji will help to better understand the effect of this intervention on these outcomes.”

The Bulabula MaPei study is a randomised controlled clinical trial testing if azithromycin given to women in labour, prevents maternal and infant infections.

Exercise during Pregnancy
Looking for exercises during pregnancy? Use this slideshow as guide to 10 easy and uncomplicated exercises.

Infections are also common in mothers with about five million cases of pregnancy-related infections occurring each year, resulting in 75,000 maternal deaths.

MCRI Professor Fiona Russell said the large clinical trials in Africa and Asia, along with the MCRI-led trial in Fiji, were likely to inform global policy related to maternal child health and hopefully benefit infants and mothers around the world.

“Administration of azithromycin during labour may be a cheap and simple intervention that could be used to improve neonatal death rates in low and-middle-income countries, alongside strengthening of maternal child health services,” she said. “This study, together with other large clinical trials, will add to evidence for the consideration of new international maternal and child health guidelines.”

Researchers from the University of Melbourne and The Royal Children’s Hospital also contributed to the review.

Source-Eurekalert